Testing effectiveness (Phase 2)Study completedNCT04470726
What this trial is testing
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype
Who this might be right for
Superficial Basal Cell CarcinomaNodular Basal Cell CarcinomaNonmelanoma Skin Cancers
AiViva BioPharma, Inc. 26